{"product_id":"rheumnow-live-2025","title":"RheumNow Live 2025","description":"\u003cul\u003e\n  \u003cli\u003eInclude: 37 videos, size: 22.78 GB\u003c\/li\u003e\n  \u003cli\u003eTarget Audience: rheumatologists and clinical immunologists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003eCourse Date: 2025\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003cp\u003eEvaluate the efficacy, safety, and clinical positioning of new biologic therapies, JAK inhibitors, and TYK2 inhibitors across various rheumatic diseases.\u003c\/p\u003e\n\u003cp\u003eImplement advanced imaging techniques for the accurate evaluation and ongoing monitoring of spondyloarthritis and vasculitis.\u003c\/p\u003e\n\u003cp\u003eDevelop comprehensive management plans for rheumatoid arthritis, addressing disease flares, multimorbidity, and the unique considerations for older adults.\u003c\/p\u003e\n\u003cp\u003eAssess aggressive treatment strategies in psoriasis to prevent psoriatic arthritis and analyze head-to-head clinical studies for optimal biologic selection.\u003c\/p\u003e\n\u003cp\u003eApply updated clinical guidelines for managing complex conditions like systemic lupus erythematosus (SLE), including new steroid protocols and the role of interferons.\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eBest for rheumatologists and clinical immunologists who want updates on biologic therapies, JAK inhibitors, RA multimorbidity, and vasculitis.\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003cp\u003eAdjourn\u003c\/p\u003e\n\u003cp\u003eAdvances in Treatment of Spondyloarthritis\u003c\/p\u003e\n\u003cp\u003eAI applied to Rheumatoid Arthritis Care Practically Not Perfect\u003c\/p\u003e\n\u003cp\u003eBIMZELX bimekizumab-bkzx Expert Perspectives on a New Treatment for PsA nr-axSpA and AS by Dr Evan Siegel\u003c\/p\u003e\n\u003cp\u003eCan Aggressive Treatment of Psoriasis Prevent PsA\u003c\/p\u003e\n\u003cp\u003eCombination Biologic Therapies in PsA\u003c\/p\u003e\n\u003cp\u003eDermatomyositis Updates Insights and JAK-Is too\u003c\/p\u003e\n\u003cp\u003eHead-to-head Studies in Psoriatic Disease What have we learned\u003c\/p\u003e\n\u003cp\u003eImaging Evaluation of Spondyloarthritis\u003c\/p\u003e\n\u003cp\u003eImaging in Vasculitis\u003c\/p\u003e\n\u003cp\u003eInterferons Role in SLE\u003c\/p\u003e\n\u003cp\u003eJAK Faculty Panel Discussion with QA\u003c\/p\u003e\n\u003cp\u003eJAK Inhibitors – POD III\u003c\/p\u003e\n\u003cp\u003eKey Considerations Managing Older Adults with RA\u003c\/p\u003e\n\u003cp\u003eKEYNOTE LECTURE Reinventing Oneself in Medicine\u003c\/p\u003e\n\u003cp\u003eManagement of EGPA in 2025 and Beyond\u003c\/p\u003e\n\u003cp\u003eModern Treatment of PMR\u003c\/p\u003e\n\u003cp\u003eMultimorbidity in RA What to Do and Who Should Do It\u003c\/p\u003e\n\u003cp\u003eOptimizing Care for PMR Advances and Challenges in Diagnosis and Treatment by Adam Brown MD Rheumatologist at C…\u003c\/p\u003e\n\u003cp\u003ePOD 7 Spondyloarthritis\u003c\/p\u003e\n\u003cp\u003ePOD I – Rheumatoid Arthritis\u003c\/p\u003e\n\u003cp\u003ePOD V Vasculitis\u003c\/p\u003e\n\u003cp\u003eProgress in Hidradenitis Supprativa\u003c\/p\u003e\n\u003cp\u003ePsoriatic Arthritis – POD II\u003c\/p\u003e\n\u003cp\u003ePsoriatic Faculty Panel Discussion with QA\u003c\/p\u003e\n\u003cp\u003eRheumatoid Faculty Panel Discussion with QA\u003c\/p\u003e\n\u003cp\u003eSpondyloarthritis Faculty Panel Discussion with QA\u003c\/p\u003e\n\u003cp\u003eSTEP Environmental Rheumatology\u003c\/p\u003e\n\u003cp\u003eSTEP Flares of Rheumatoid Arthritis\u003c\/p\u003e\n\u003cp\u003eSTEP Morphea and Linear Scleroderma\u003c\/p\u003e\n\u003cp\u003eSTEP New Steroid Rules for Lupus\u003c\/p\u003e\n\u003cp\u003eSTEP Oral Surveillance 3 years later\u003c\/p\u003e\n\u003cp\u003eSTEP Performance Art and Medicine\u003c\/p\u003e\n\u003cp\u003eTYK2 Inhibitors Where do they fit\u003c\/p\u003e\n\u003cp\u003eVasculitis Faculty Panel Discussion with QA\u003c\/p\u003e\n\u003cp\u003eWelcome Introductions\u003c\/p\u003e\n\u003cp\u003eWhen JAKs Go Generic\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405813141700,"sku":null,"price":97.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/RheumNow-Live-2025.jpg?v=1784216563","url":"https:\/\/medicalcoursespro.com\/products\/rheumnow-live-2025","provider":"Medicalcoursespro","version":"1.0","type":"link"}